More on Intercept Pharma Q2 results

Intercept Pharmaceuticals (NASDAQ:ICPT) Q2 results: Revenues: $0.4M (-9.0%); Net Loss: ($13.5M) (-140.3%); Loss Per Share: ($0.79) (-152.3%); Quick Assets: $144.8M (-51.6%).

No financial guidance given.

From other sites
Comments (1)
  • sibtiger
    , contributor
    Comment (1) | Send Message
    This was last year's Q2 results!
    12 Aug 2014, 12:06 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs